<DOC>
	<DOCNO>NCT02303314</DOCNO>
	<brief_summary>This study design examine performance trigonella foenum-graecum ( TFG ) treatment non-alcoholic fatty liver disease . Base inclusion exclusion criterion , 50 patient select randomize intervention control group . Two group use capsule contain TFG placebo , respectively .</brief_summary>
	<brief_title>Efficacy Oral Trigonella Foenum-graecum Seed Extract Vs Placebo Treatment None Alcoholic Fatty Liver Disease</brief_title>
	<detailed_description>This study design examine performance trigonella foenum-graecum treatment non-alcoholic fatty liver disease . Patients 18-70 year old level ALT AST great 1.5 less 10 time normal level , ultrasound evidence confirm fatty liver disease include study . Patients alcohol consumption , liver disease take medication cause liver injury , exclude . Base inclusion exclusion criterion , 50 patient select randomize intervention control group . Control group , addition diet exercise recommendation take placebo capsule 3 month . Intervention group , addition diet exercise recommendation , use capsule contain hydro-alcoholic extract fenugreek 1g/d 3 month . At baseline 6 12 week intervention , investigator measure FBS , insulin , insulin resistance , Albumin , Aspartate transaminase , Alanine Aminotransferase , Alkaline phosphatase , Total bilirubin , Direct bilirubin , HbA1c , total cholesterol , LDL , HDL , TG , High sensitivity C reactive protein Creatinine . At baseline 12 week intervention fibroscan perform evaluate amount fat liver . In order decrease bias , patient , physician performs fibroscan person analyze data blind group drug .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Inclusion criterion : The level ALT AST great 1.5 less 10 time normal level Ultrasound evidence confirm fatty liver disease ; age 1870 year old Negative pregnancy test woman reproductive age ( two week prior study ) Negative hepatitis B C BMI : 18.5 40 Sign consent form . Exclusion criterion : History one unit alcohol consumption ( one value Spirits ( vodka ; whiskey ) Wine Beer respectively 3045 cc ; 120150 cc 360 cc . ) Fatty liver controller medication Glucose lower drug Cholesterol lower drug Hypotensive drug Consumption vitamin E Taking coenzyme Q10 Administration corticosteroid &amp; glucocorticoid Thyroxin administration Administration drug cause fatty liver Diabetes ( type 1 2 ) History cancer past Hepatocellular carcinoma Renal failure ( creatinine &gt; 1.5 x ULN ) Chronic pancreatitis Cirrhosis Uncontrolled hypertension ( 180 mm Hg systolic blood pressure ) ; heart disease Autoimmune hepatitis Primary biliary cirrhosis Primary sclerosing cholangitis ( alkaline phosphatase level great 3 time normal ) Wilson 's disease Alpha1 antitrypsin deficiency coronary artery disease Symptoms hypothyroidism Hyperthyroidism Disorders hypothalamic pituitary Liver transplantation Pregnant lactate woman Those use contraceptive .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>